Skip to Content

BURNEZE SPRAY

Active substance(s): BENZOCAINE

View full screen / Print PDF » Download PDF ⇩
Transcript
Common Technical Document
Module 1 – Administrative and Prescribing Information
Module 1.3 – Product Information

Burneze Spray

Text to appear on the Patient Information Leaflet

BURNEZE SPRAY
Benzocaine 1% w/w
PATIENT INFORMATION LEAFLET
Please read this leaflet carefully before using Burneze Spray.
• Keep this leaflet, you may wish to read it again.
• Ask your pharmacist if you need more information or advice.
What is this spray used for?
Burneze Spray contains local anaesthetic called Benzocaine which relieves pain. This spray solution
is applied to the skin to relieve pain from minor superficial burns and scalds, where the skin is
unbroken.
Before using this spray
Do not use…
• If you are allergic to the active ingredient or to any of other ingredients in this product or
any chemically related anaesthetics (butylcaine and tetracaine) or para-aminobenzoic acid,
parabens or paraphenylenediamine or to commercial hair dyes. See 'what this spray contains'
for the full list of ingredients.
• On large areas, eczematous (A skin inflammation characterized chiefly by redness, itching,
and the outbreak of lesions that may discharge serous matter and become encrusted and
scaly), infected or on broken skin or on face.
• In or near to the eyes or mouth, or under conditions in which significant inhalation is likely.
• On children under 12 years old
Take special care…
• If you are pregnant or breast feeding speak to your doctor or pharmacist before using.
• Burneze spray is for external use only.
• Avoid freezing the skin by repeated or prolonged use.
Seek medical attention if the burns are extensive (especially in young children or if they affect
fingers, toes or sensitive areas).
How to use this spray
To reduce pain and blistering use Burneze spray as quickly as possible.
• Hold the nozzle 12.5 cm (5 inches) from the skin.
• Press down firmly and spray once for 2 to 3 seconds.
Stop spraying straight away if a white deposit (frost) appears.
• If necessary the application may be repeated once only after 15 minutes.
If pain persists, speak to your doctor or pharmacist.

January 2015 - LB

Common Technical Document
Module 1 – Administrative and Prescribing Information
Module 1.3 – Product Information

Burneze Spray

Possible side effects
As with all medicines, this spray can have side effects in some people.
• In sensitive people it may allergic skin reactions, such as itching, redness, blisters, nettle
rash (hives).
• General allergic reactions
• A blood condition called methaemoglobinaemia which can cause headache, breathlessness
and blue-tinged skin, may occur rarely, especially in infants and children.
If you feel you are reacting badly to this medicine in any way, or notice any other side effects not
listed in this leaflet, please tell your doctor or pharmacist.
How to store this spray
• Keep out of the sight and reach of children.
• Do not store above 25°C and keep away from heat and sunlight.
• Caution Flammable: Do not use near fire or flame.
Pressurised container. Protect from sunlight and do not expose to temperatures exceeding
50°C. Do not pierce or burn, even after use. Do not use near or place container on polished
or painted surfaces.
• Do not use after expiry date shown base of the can.
• If you find that you still have this medicine after its expiry date, return it to your local
pharmacist who will dispose of it properly.
What this spray contains
Burneze spray contains % by weight of the active ingredient benzocaine.
It also contains denatured ethanol, n-pentane and iso-butane.
The physical effect of the cooling excipients helps reduce pain and blistering.
Burneze spray is available in aluminium cans containing 60ml of cutaneous spray, solution to be
applied topically to the affected area.
Marketing Authorisation Holder: G R Lane Health Products Ltd. Sisson Road, Gloucester, GL2
0GR UK
Manufactured by: ColepCCL Rapid-Spray GmbH & Co. KG, Fockestrasse 12, 88471 Laupheim,
Germany.
Date of revision: September 2013
Product license number; PL 01074/0239
Burneze is a trade mark of G R Lane Health Products Ltd.

January 2015 - LB

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide